Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02709785 · ClinicalTrials.gov registry record · NA
SmartMouth Advanced Clinical Formula Clinical Research Design Protocol
A NA study, sponsored by St. Louis University.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT02709785 is a NA study that has completed, run by St. Louis University. The registered enrollment target is 80 participants.
The verdict
NCT02709785, a NA study, has completed, sponsored by St. Louis University.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
The aim of this study is to provide evidence on the clinical efficacy of SmartMouth Advanced Clinical Formula mouthrinse in comparison to the efficacy of 0.12% chlorhexidine mouthrinse and a placebo mouthrinse. The placebo will be provided by the sponsor and will be identical to SmartMouth ACF (Advanced Clinical Formula), except it will not contain cetylpyridinium chloride, zinc chloride and sodium chlorite. The primary outcomes include measures of plaque and gingivitis. Secondary outcomes include evaluation of tooth discoloration, taste perception, malodor and calculus.
Interventions
- DRUG SmartMouth Clinical DDS mouthrinse
- DRUG 0.12% chlorhexidine rinse
- DRUG Placebo rinse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2016-03 |
| Est. Completion | 2017-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02709785
The ClinicalTrials.gov registry entry for NCT02709785 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Louis University, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which SmartMouth Clinical DDS mouthrinse is the first listed.
NCT02709785 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02709785 about?
NCT02709785 is a clinical study titled "SmartMouth Advanced Clinical Formula Clinical Research Design Protocol". The aim of this study is to provide evidence on the clinical efficacy of SmartMouth Advanced Clinical Formula mouthrinse in comparison to the efficacy of 0.12% chlorhexidine mouthrinse and a placebo mouthrinse. The placebo will be provided by the sponsor and will be identical to SmartMouth ACF (Adva...
What is the current status of trial NCT02709785?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2016-03. Estimated completion is 2017-05.
What interventions are being tested in trial NCT02709785?
The interventions under investigation include: SmartMouth Clinical DDS mouthrinse (DRUG), 0.12% chlorhexidine rinse (DRUG), Placebo rinse (DRUG).
Who is sponsoring clinical trial NCT02709785?
This trial is sponsored by St. Louis University, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.